This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Genzyme Corporation, Medtronic, Inc.. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Greg Stewart: Innovator in Gene Therapy
Introduction
Greg Stewart is a prominent inventor based in Plymouth, MN (US). He has made significant contributions to the field of gene therapy, particularly in addressing neurometabolic disorders. With a total of 2 patents, his work focuses on innovative methods for treating complex neurological conditions.
Latest Patents
One of Greg Stewart's latest patents involves gene therapy for neurometabolic disorders. This patent discloses methods and compositions for treating disorders affecting the central nervous system (CNS), including lysosomal storage diseases such as Niemann-Pick A disease and Alzheimer's disease. The methods involve contacting an axonal ending of a neuron with a composition containing high titer AAV carrying a therapeutic transgene. This allows the AAV vector to be axonally transported in a retrograde fashion, leading to the expression of the transgene product distally to the administration site. Another significant patent focuses on methods for distributing agents to areas of the brain. This patent outlines that broad cerebrospinal fluid (CSF) distribution of an agent can be achieved by delivering the agent in a liquid formulation to the CSF at flow rates less than 500 microliters per hour, specifically between about 2 microliters per hour and about 100 microliters per hour.
Career Highlights
Throughout his career, Greg Stewart has worked with notable companies such as Medtronic, Inc. and Genzyme Corporation. His experience in these organizations has contributed to his expertise in the field of gene therapy and neurometabolic disorders.
Collaborations
Greg has collaborated with several professionals in his field, including Deepak Ramesh Thakker and Lisa Lynn Shafer. These collaborations have further enhanced his research and development efforts in innovative therapies.
Conclusion
Greg Stewart is a dedicated inventor whose work in gene therapy is paving the way for new treatments for neurometabolic disorders. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile